|Articles|October 1, 2001
Evidence-based approach best for cancer management tools
Anaheim, Calif. - Topical imiquimod, systemic retinoids, and sentinellymph node biopsies are dermatologic tools that instigate promise and controversywhen discussing their role in managing basal cell carcinoma, squamous cellcarcinoma, and primary cutaneous melanoma, respectively.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
4
Top 5 Articles of the Week: December 7-12
5














